Patient-Reported Burden of Adverse Drug Reactions Attributed to Biologics Used for Immune-Mediated Inflammatory Diseases.
Jette A van LintNaomi T JessurunRenske C F HebingFrank HoentjenSander W TasHarald E VonkemanMartijn B A van DoornAnnemieke SobelsPhyllis I SpulsEugene P van PuijenbroekMichael T NurmohamedBartholomeus J F van den BemtPublished in: Drug safety (2021)
The patient perspective gives important insights into the burden of ADRs experienced with biologics. This information could be used by healthcare professionals to optimise treatment with biologics.